Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
Regulatory Post-Marketing Surveillance Study for Brolucizumab |
Neovascular Age-related Macular Degeneration | Korea, Republic of | NCT04985487 | |
Efficacy, Safety and Tolerability of KLU156 in Adults and Children ≥ 5 kg Body Weight With Uncomplicated P. Falciparum Malaria |
Uncomplicated Plasmodium Falciparum Malaria | Phase3 | Burkina Faso Congo, The Democratic Republic of the Côte D'Ivoire Gabon Ghana India Kenya Mali Niger Rwanda Tanzania Uganda Zambia View All |
NCT05842954 |
A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea |
Graft-versus-Host Disease | Korea, Republic of | NCT05621733 | |
Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function |
Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Phase2 | France Germany Italy Spain United States View All |
NCT06004661 |
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria |
Uncomplicated Plasmodium Falciparum Malaria | Phase2 | Burkina Faso Côte D'Ivoire Gabon Ghana Kenya Uganda View All |
NCT05750628 |
A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC |
Prostatic Neoplasm | Phase2 | Brazil Canada China Czechia France Germany Italy Korea, Republic of Netherlands Poland Singapore Spain United States View All |
NCT05849298 |
A Study of Rapcabtagene Autoleucel in Systemic Lupus Erythematosus (SLE) Patients With Active, Refractory Lupus Nephritis (LN) |
Lupus Erythematosus, Systemic, Lupus Nephritis | Phase2 | Czechia France Germany Italy Japan Korea, Republic of Netherlands Romania Singapore Spain Switzerland Taiwan United Kingdom United States View All |
NCT06581198 |
Secukinumab Open Label Roll-over Extension Protocol |
Autoimmunity, Inflammation | Phase4 | Brazil Bulgaria China Colombia Czechia Guatemala Italy Poland Portugal Russian Federation South Africa Spain Switzerland United States View All |
NCT04638647 |
Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT |
Prostate Cancer | Phase1, Phase2 | Australia Canada France United States View All |
NCT05983198 |
Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis |
Multiple Sclerosis | Phase4 | Taiwan | NCT04480853 |